Rosetta Genomics Ltd.

12.11.2016 | NASDAQ

ZAG-S&W represented Aegis Capital Corp. as Lead Placement Agent in a private placement offering of Rosetta Genomics

Attorneys Oded Har-Even, Shy Baranov, Rob Condon, Ron Ben-Bassat  Hila Nahum and  Adi Israel represented Aegis Capital Corp. as lead placement agent in an approximately $4.5 million concurrent registered direct and private placement offering of ordinary shares, debentures and warrants by Rosetta Genomics, which develops and commercializes a full range of microRNA-based and other molecular diagnostics.




Recent Activity